These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31546720)

  • 1. Why, Who, When, and How? Rationale for Considering Allogeneic Stem Cell Transplantation in Children with Sickle Cell Disease.
    Bernaudin F
    J Clin Med; 2019 Sep; 8(10):. PubMed ID: 31546720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the place of hematopoietic stem cell transplantation in the management of cerebral vasculopathy in children with sickle cell anemia?
    Bernaudin F
    Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):121-130. PubMed ID: 32202243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia.
    Bernaudin F; Pondarré C; Galambrun C; Thuret I
    Adv Exp Med Biol; 2017; 1013():89-122. PubMed ID: 29127678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Matched Sibling Donor Hematopoietic Stem Cell Transplantation With Transcranial Doppler Velocities in Children With Sickle Cell Anemia.
    Bernaudin F; Verlhac S; Peffault de Latour R; Dalle JH; Brousse V; Petras E; Thuret I; Paillard C; Neven B; Galambrun C; Divialle-Doumdo L; Pondarré C; Guitton C; Missud F; Runel C; Jubert C; Elana G; Ducros-Miralles E; Drain E; Taïeb O; Arnaud C; Kamdem A; Malric A; Elmaleh-Bergès M; Vasile M; Leveillé E; Socié G; Chevret S;
    JAMA; 2019 Jan; 321(3):266-276. PubMed ID: 30667500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic cellular gene therapy in hemoglobinopathies--evaluation of hematopoietic SCT in sickle cell anemia.
    Lucarelli G; Gaziev J; Isgrò A; Sodani P; Paciaroni K; Alfieri C; De Angelis G; Marziali M; Simone MD; Gallucci C; Roveda A; Saltarelli F; Torelli F; Andreani M
    Bone Marrow Transplant; 2012 Feb; 47(2):227-30. PubMed ID: 21499319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of hematopoietic stem cell transplantation in hemoglobinopathies: thalassemia major and sickle cell disease].
    Hladun R; Elorza I; Olivé T; Dapena JL; Llort A; Sánchez de Toledo J; Díaz de Heredia C
    An Pediatr (Barc); 2013 Aug; 79(2):75-82. PubMed ID: 23402775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404).
    Chevret S; Verlhac S; Ducros-Miralles E; Dalle JH; de Latour RP; de Montalembert M; Benkerrou M; Pondarré C; Thuret I; Guitton C; Lesprit E; Etienne-Julan M; Elana G; Vannier JP; Lutz P; Neven B; Galambrun C; Paillard C; Runel C; Jubert C; Arnaud C; Kamdem A; Brousse V; Missud F; Petras M; Doumdo-Divialle L; Berger C; Fréard F; Taieb O; Drain E; Elmaleh M; Vasile M; Khelif Y; Bernaudin M; Chadebech P; Pirenne F; Socié G; Bernaudin F
    Contemp Clin Trials; 2017 Nov; 62():91-104. PubMed ID: 28821470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic stem cell transplantation for children with severe aplastic anemia.
    Hutspardol S; Sirachainan N; Anurathapan U; Pakakasama S; Songdej D; Chuansumrit A; Sirireung S; Panthangkool W; Hongeng S
    J Med Assoc Thai; 2013 Jan; 96 Suppl 1():S18-24. PubMed ID: 23724451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease.
    Kassim AA; DeBaun MR
    Expert Opin Pharmacother; 2014 Feb; 15(3):325-36. PubMed ID: 24392871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic approaches in sickle cell disease].
    Joseph L; Arlet JB; Bernaudin F; Dhédin N
    Rev Prat; 2023 May; 73(5):535-539. PubMed ID: 37309792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Characterization of Hematopoietic Stem Cell Transplant Candidates in a Sickle Cell Disease Cohort.
    Flor-Park MV; Kelly S; Preiss L; Custer B; Carneiro-Proietti ABF; Araujo AS; Loureiro P; Maximo C; Rodrigues DOW; Mota RA; Sabino EC; Rocha V;
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2103-2109. PubMed ID: 31229639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current attitudes of parents and patients toward hematopoietic stem cell transplantation for sickle cell anemia.
    Meier ER; Dioguardi JV; Kamani N
    Pediatr Blood Cancer; 2015 Jul; 62(7):1277-84. PubMed ID: 25809231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape.
    Kassim AA; Sharma D
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):259-266. PubMed ID: 28641096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How I treat ... sickle cell anemia: current therapies].
    Rezaei Kalantari H
    Rev Med Liege; 2001 Oct; 56(10):671-5. PubMed ID: 11765575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases.
    Arnold SD; Brazauskas R; He N; Li Y; Aplenc R; Jin Z; Hall M; Atsuta Y; Dalal J; Hahn T; Khera N; Bonfim C; Majhail NS; Diaz MA; Freytes CO; Wood WA; Savani BN; Kamble RT; Parsons S; Ahmed I; Sullivan K; Beattie S; Dandoy C; Munker R; Marino S; Bitan M; Abdel-Azim H; Aljurf M; Olsson RF; Joshi S; Buchbinder D; Eckrich MJ; Hashmi S; Lazarus H; Marks DI; Steinberg A; Saad A; Gergis U; Krishnamurti L; Abraham A; Rangarajan HG; Walters M; Lipscomb J; Saber W; Satwani P
    Haematologica; 2017 Nov; 102(11):1823-1832. PubMed ID: 28818869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
    Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
    Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle Cell Disease: A Brief Update.
    Azar S; Wong TE
    Med Clin North Am; 2017 Mar; 101(2):375-393. PubMed ID: 28189177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disease modifying treatments for sickle cell disease].
    Pondarré C; Lionnet F
    Rev Prat; 2023 May; 73(5):522-526. PubMed ID: 37309788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell transfusions during sickle cell anemia vaso-occlusive crises: a report from the magnesium in crisis (MAGiC) study.
    Hulbert ML; Panepinto JA; Scott JP; Liem RI; Cook LJ; Simmons T; Brousseau DC;
    Transfusion; 2017 Aug; 57(8):1891-1897. PubMed ID: 28500682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.